The hunt narrows for ebolavirus hosts
Peer-Reviewed Publication
Updates every hour. Last Updated: 6-May-2025 22:09 ET (7-May-2025 02:09 GMT/UTC)
Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company has recently announced the breakthrough study achieved in collaboration with a well-known university in Hong Kong. Targeting endometriosis, a condition that affects more than 190 million women worldwide, the researchers used Insilico’s PandaOmics, the artificial intelligence-driven platform, to identify two novel therapeutic targets and a FDA approved drug as a potential repurposed treatment option. The findings were published in December 2024 in Advanced Science(IF=15.1).
The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve brain health, today announced the launch of its Brain Health Navigator program. The initiative led by the DAC Healthcare System Preparedness (DAC-SP) team will provide resources for patients and providers at six sites across the U.S.